Your browser doesn't support javascript.
loading
Challenges in tackling energy expenditure as obesity therapy: From preclinical models to clinical application.
Löffler, Mona C; Betz, Matthias J; Blondin, Denis P; Augustin, Robert; Sharma, Anand K; Tseng, Yu-Hua; Scheele, Camilla; Zimdahl, Heike; Mark, Michael; Hennige, Anita M; Wolfrum, Christian; Langhans, Wolfgang; Hamilton, Bradford S; Neubauer, Heike.
Afiliación
  • Löffler MC; Cardio Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.
  • Betz MJ; Department of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland.
  • Blondin DP; Department of Medicine, Division of Neurology, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, QC, Canada.
  • Augustin R; Cardio Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.
  • Sharma AK; Institute of Food, Nutrition and Health, ETH Zürich, Schwerzenbach, Switzerland.
  • Tseng YH; Joslin Diabetes Center, Section on Integrative Physiology and Metabolism, Harvard Medical School, Boston, MA, USA; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.
  • Scheele C; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Denmark.
  • Zimdahl H; Cardio Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.
  • Mark M; Cardio Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.
  • Hennige AM; Therapeutic Area CardioMetabolism & Respiratory, Boehringer Ingelheim International GmbH, Biberach, Germany.
  • Wolfrum C; Institute of Food, Nutrition and Health, ETH Zürich, Schwerzenbach, Switzerland.
  • Langhans W; Physiology and Behavior Laboratory, Department of Health Sciences and Technology, ETH Zürich, Switzerland.
  • Hamilton BS; Cardio Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.
  • Neubauer H; Cardio Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany. Electronic address: heike.neubauer@boehringer-ingelheim.com.
Mol Metab ; 51: 101237, 2021 09.
Article en En | MEDLINE | ID: mdl-33878401
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ingestión de Energía / Metabolismo Energético / Obesidad Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Metab Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ingestión de Energía / Metabolismo Energético / Obesidad Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Metab Año: 2021 Tipo del documento: Article País de afiliación: Alemania